Market Overview

Leukapheresis Market by Product, Leukopak, Application, End User - Global Forecast to 2023 - ResearchAndMarkets.com

Share:

The "Leukapheresis
Market by Product, Leukopak, Application, End User - Global Forecast to
2023"
report has been added to ResearchAndMarkets.com's
offering.

The leukapheresis products market is expected to reach USD 27.7 million
by 2023 from an estimated USD 19.4 million in 2018, at a CAGR of 7.4%.

The leukopaks market is expected to reach USD 445.6 million by 2023, at
a CAGR of 46.4%. Leukopaks are enriched leukapheresis products that
contain higher concentrations of leukocytes. The increasing incidence
and prevalence of leukemia and growing demand for leukopaks for research
applications are some of the factors driving the growth of these
markets. However, the high cost of therapeutic leukapheresis and
leukopaks and stringent donor recruitment criteria are restraining the
growth of this market to a certain extent.

By type, the leukapheresis products market is segmented into
leukapheresis devices and leukapheresis disposables. The leukapheresis
devices segment is further subsegmented into apheresis devices,
leukapheresis columns & cell separators, and leukoreduction filters. The
leukoreduction filters segment is expected to register the highest CAGR
during the forecast period. This high growth-rate can be attributed to
the increasing adoption of leukoreduction filters by researchers.

On the basis of type, the leukopaks market is segmented into mobilized
leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated
PBMCs. The isolated PBMCs segment is expected to register the highest
CAGR during the forecast period. This growth can be attributed to the
increasing focus of researchers on cell-based therapies including CAR-T
therapy targeted development.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Leukapheresis Products Market, By Type

8 Leukapheresis Products Market, By Application

9 Leukapheresis Products Market, By End User

10 Leukopaks Market

11 Geographic Analysis

12 Competitive Landscape

13 Company Profiles

  • Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
  • Fresenius Se & Co. KGaA
  • Haemonetics Corporation
  • Hemacare Corporation
  • Key Biologics, LLC.
  • Terumo BCT
  • ALLCells, LLC.
  • Stemexpress, LLC.
  • Stemcell Technologies, Inc.
  • Caltag Medsystems Limited
  • Zenbio, Inc.
  • Precision for Medicine, Inc.
  • PPA Research Group, Inc.
  • Bioivt
  • Macopharma SA

For more information about this report visit https://www.researchandmarkets.com/research/b8k282/leukapheresis?w=4

View Comments and Join the Discussion!